Peter Young, president of AlphaVax, a biotechnology company dedicated to the development of vaccines based on innovative technology, has been elected to the board of directors of Biotechnology Industry Organization (BIO).

Young has worked with BIO’s Emerging Company Section Governing Body for the past year. He is also chairman of NC BIO, the state industry association in North Carolina.

“A decade ago North Carolina was instrumental in the early formation of BIO as a unified voice for the new biotechnology industry,” said Young. “It is a privilege to serve on the board of this important organization and help expand the transformational medical and economic impact of biotechnology on both a state and national level.”

AlphaVax: www.alphavax.com